Elevated markers of VEGF in patients with depressive disorders, including gene polymorphisms, VEGF mRNA expression, and plasma VEGF levels, suggest a neuroprotective role for VEGF in response to clinical depressive states [94,95,96]. Here, VEGFA is linked to depressive disorder.